NDLI: Epidemiology and outcomes of renal replacement therapy: results from the ERA-EDTA registry

Content Provider	Semantic Scholar
Author	Kramer, Anneke
Copyright Year	2011
Abstract	Anneke Kramer onderzocht de epidemiologie van nierfunctievervangende therapie (dialyse of transplantatie) bij zeer ernstig nierfalen. De prevalentie van chronische nierschade is redelijk gelijk binnen Europa. De incidentie van nierfunctievervangende therapie in Europa was lang stijgende maar blijft de laatste jaren min of meer stabiel, zo blijkt uit Kramers onderzoek. Wereldwijd verschilt de incidentie van nierfunctievervangende therapie sterk. In landen die meer geld beschikbaar hebben voor de gezondheidszorg lijkt nierfunctievervangende therapie vaker te worden toegepast, maar is ook sprake van slechtere overleving bij dialyse. De overleving van kinderen met ernstig nierfalen daalt niet significant wanneer voorafgaand aan niertransplantatie een of twee jaar wordt gedialyseerd. Toch hebben kinderen de beste overlevingskansen als zij een functionerend niertransplantaat hebben op de leeftijd van 18 jaar. Voor volwassen patienten lijkt er geen verband te zijn tussen het type dialyse (hemodialyse of peritoneaal dialyse) in de jaren voor niertransplantatie en de overleving na transplantatie.
File Format	PDF HTM / HTML
Alternate Webpage(s)	https://pure.uva.nl/ws/files/1566140/100651_07.pdf
Alternate Webpage(s)	https://pure.uva.nl/ws/files/1566148/100655_11.pdf
Alternate Webpage(s)	https://pure.uva.nl/ws/files/1566146/100654_10.pdf
Alternate Webpage(s)	https://pure.uva.nl/ws/files/1566150/100656_12.pdf
Alternate Webpage(s)	https://pure.uva.nl/ws/files/1566142/100652_08.pdf
Alternate Webpage(s)	https://pure.uva.nl/ws/files/1566138/100650_06.pdf
Alternate Webpage(s)	https://pure.uva.nl/ws/files/1566158/100660_16.pdf
Alternate Webpage(s)	https://pure.uva.nl/ws/files/1566154/100658_14.pdf
Alternate Webpage(s)	https://pure.uva.nl/ws/files/1566126/100644_thesis.pdf
Alternate Webpage(s)	https://pure.uva.nl/ws/files/1566152/100657_13.pdf
Alternate Webpage(s)	https://pure.uva.nl/ws/files/1566144/100653_09.pdf
Alternate Webpage(s)	https://pure.uva.nl/ws/files/1566136/100649_05.pdf
Alternate Webpage(s)	https://pure.uva.nl/ws/files/1566130/100646_02.pdf
Language	English
Access Restriction	Open
Content Type	Text
Resource Type	Article

Central Library (ISO-9001:2015 Certified)
Indian Institute of Technology Kharagpur
Kharagpur, West Bengal, India | PIN - 721302

See location in the Map
03222 282435
Mail: support@ndl.gov.in

Sl.	Authority	Responsibilities	Communication Details
1	Ministry of Education (GoI), Department of Higher Education	Sanctioning Authority	https://www.education.gov.in/ict-initiatives
2	Indian Institute of Technology Kharagpur	Host Institute of the Project: The host institute of the project is responsible for providing infrastructure support and hosting the project	https://www.iitkgp.ac.in
3	National Digital Library of India Office, Indian Institute of Technology Kharagpur	The administrative and infrastructural headquarters of the project	Dr. B. Sutradhar bsutra@ndl.gov.in
4	Project PI / Joint PI	Principal Investigator and Joint Principal Investigators of the project	Dr. B. Sutradhar bsutra@ndl.gov.in Prof. Saswat Chakrabarti will be added soon
5	Website/Portal (Helpdesk)	Queries regarding NDLI and its services	support@ndl.gov.in
6	Contents and Copyright Issues	Queries related to content curation and copyright issues	content@ndl.gov.in
7	National Digital Library of India Club (NDLI Club)	Queries related to NDLI Club formation, support, user awareness program, seminar/symposium, collaboration, social media, promotion, and outreach	clubsupport@ndl.gov.in
8	Digital Preservation Centre (DPC)	Assistance with digitizing and archiving copyright-free printed books	dpc@ndl.gov.in
9	IDR Setup or Support	Queries related to establishment and support of Institutional Digital Repository (IDR) and IDR workshops	idr@ndl.gov.in

Characteristics and Outcomes of Patients With Systemic Sclerosis (Scleroderma) Requiring Renal Replacement Therapy in Europe: Results From the ERA-EDTA Registry.

The changing trends and outcomes in renal replacement therapy: data from the ERA-EDTA Registry

Deposit disease: an era-edta registry study.

Fifty years of ERA-EDTA Registry-a registry in transition.

Rare diseases in renal replacement therapy in the era-edta registry.

Renal replacement therapy in Europe: the results of a collaborative effort by the ERA–EDTA registry and six national or regional registries

Characteristics and Outcomes of Patients With Systemic Sclerosis (Scleroderma) Requiring Renal Replacement Therapy in Europe: Results From the ERA-EDTA Registry

Outcomes of renal replacement therapy in boys with prune belly syndrome: findings from the ESPN/ERA-EDTA Registry

Renal replacement therapy for autosomal dominant polycystic kidney disease (ADPKD) in Europe: prevalence and survival—an analysis of data from the ERA-EDTA Registry

Epidemiology and outcomes of renal replacement therapy: results from the ERA-EDTA registry

Similar Documents

Characteristics and Outcomes of Patients With Systemic Sclerosis (Scleroderma) Requiring Renal Replacement Therapy in Europe: Results From the ERA-EDTA Registry.

The changing trends and outcomes in renal replacement therapy: data from the ERA-EDTA Registry

Deposit disease: an era-edta registry study.

Fifty years of ERA-EDTA Registry-a registry in transition.

Rare diseases in renal replacement therapy in the era-edta registry.

Renal replacement therapy in Europe: the results of a collaborative effort by the ERA–EDTA registry and six national or regional registries

Characteristics and Outcomes of Patients With Systemic Sclerosis (Scleroderma) Requiring Renal Replacement Therapy in Europe: Results From the ERA-EDTA Registry

Outcomes of renal replacement therapy in boys with prune belly syndrome: findings from the ESPN/ERA-EDTA Registry

Renal replacement therapy for autosomal dominant polycystic kidney disease (ADPKD) in Europe: prevalence and survival—an analysis of data from the ERA-EDTA Registry

Epidemiology and outcomes of renal replacement therapy: results from the ERA-EDTA registry